Help | RSS Feed

Luminex Corp. (NASD:LMNX) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Luminex Corp. (NASD:LMNX) seasonal charts above shows that a Buy Date of April 24 and a Sell Date of September 15 has resulted in a geometric average return of 8.85% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 15.11% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Luminex Corp is a biotechnology company that develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. The company primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex’s market segments mainly include infectious disease, genetic or inherited disease, personalized medicine, and life sciences research. It offers various solutions in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, and food safety. The vast majority of the company’s revenue is earned in the United States.

To download LMNX seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z